Letters Drug pricing

Misconceptions about PPRS

BMJ 2007; 335 doi: https://doi.org/10.1136/bmj.39339.449641.3A (Published 20 September 2007) Cite this as: BMJ 2007;335:578
  1. Aisling Burnand, chief executive
  1. BioIndustry Association, London SW1X 8PS
  1. kmurphy{at}bioindustry.org

Iheanacho argues that the Office of Fair Trading may have pinpointed some areas of improvement in the existing Pharmaceutical Price Regulation Scheme (PPRS).1 However, its proposals for introducing a value based system of drug pricing are inherently flawed and, if implemented, would lead to a significant erosion of …

View Full Text

Log in

Log in through your institution


* For online subscription